Product Information
VERAPAMIL 120 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.0858 per EA under NDC 00591034501. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
120 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591034501
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA070994On Market Since
10/1/1986
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL 120 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 3.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0858 per EA |
|---|---|
| All-time high | $0.0896 (Jun 10, 2015) |
| All-time low | $0.0564 (Dec 20, 2017) |
| 52-week high | $0.0883 |
| 52-week low | $0.0731 |
| Median price | $0.0698 |
| Average price | $0.0711 |
| Largest weekly change | -26.5% (Jan 18, 2017) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VERAPAMIL 120 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL 120 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.0858 per EA (NDC 00591034501), effective Jun 24, 2026.
How has the price of VERAPAMIL 120 MG TABLET changed over time?
Over the history we have for it, the NADAC for VERAPAMIL 120 MG TABLET has risen 3.2%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VERAPAMIL 120 MG TABLET?
Since Nov 28, 2013, the NADAC for VERAPAMIL 120 MG TABLET has ranged from a low of $0.0564 (Dec 20, 2017) to a high of $0.0896 (Jun 10, 2015), with a median of $0.0698 per EA.
Are there cheaper alternatives to VERAPAMIL 120 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as VERAPAMIL 120 MG TABLET, but none are currently priced below it.
Who manufactures VERAPAMIL 120 MG TABLET?
VERAPAMIL 120 MG TABLET (NDC 00591034501) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification